These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 7905217

  • 1. [Survival of patients with zidovudine resistant HIV].
    Gøtzsche PC, Nielsen C, Gerstoft J, Nielsen CM, Vestergaard BF.
    Ugeskr Laeger; 1994 Jan 10; 156(2):185-6. PubMed ID: 7905217
    [Abstract] [Full Text] [Related]

  • 2. Trend towards decreased survival in patients infected with HIV resistant to zidovudine.
    Gøtzsche PC, Nielsen C, Gerstoft J, Nielsen CM, Vestergaard BF.
    Scand J Infect Dis; 1992 Jan 10; 24(5):563-5. PubMed ID: 1361240
    [Abstract] [Full Text] [Related]

  • 3. Prolonged suppression of human immunodeficiency virus type 1 (HIV-1) viremia in persons with advanced disease results in enhancement of CD4 T cell reactivity to microbial antigens but not to HIV-1 antigens.
    Rinaldo CR, Liebmann JM, Huang XL, Fan Z, Al-Shboul Q, McMahon DK, Day RD, Riddler SA, Mellors JW.
    J Infect Dis; 1999 Feb 10; 179(2):329-36. PubMed ID: 9878015
    [Abstract] [Full Text] [Related]

  • 4. Zidovudine monotherapy versus zidovudine plus zalcitabine combination therapy in HIV-positive persons with CD4 cell counts 300-500 cells/mm3: a double-blind controlled trial. The M50003 Study Group Coordinating and Writing Committee.
    Moyle GJ, Bouza E, Antunes F, Smith D, Harris R, Warburg M, Walker M.
    Antivir Ther; 1997 Dec 10; 2(4):229-36. PubMed ID: 11327442
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Zidovudine therapy, CD4+ and CD8+ counts are associated with a longer survival following AIDS onset.
    Fiala M, Swartz J, Teklehaimanot S, Kermani V, Funnye AS, Sayre JW, Gornbein JA.
    Lymphology; 1997 Sep 10; 30(3):128-36. PubMed ID: 9313205
    [Abstract] [Full Text] [Related]

  • 7. Survival of patients receiving zidovudine before or after AIDS diagnosis: results of a German multicenter study. German AIDS Study Group.
    Clin Investig; 1994 Jan 10; 72(2):111-6. PubMed ID: 8186655
    [Abstract] [Full Text] [Related]

  • 8. In vitro cytopathogenicity of the human immunodeficiency virus (HIV)-1 predicts survival in HIV-infected hemophiliacs independent from CD4 cell count.
    Rockstroh JK, Woitas RP, Brackmann HH, Kupfer B, Kaiser R, Schneweis KE, Sudhop T, Spengler U.
    Eur J Med Res; 1998 May 12; 3(5):223-30. PubMed ID: 9580568
    [Abstract] [Full Text] [Related]

  • 9. A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy.
    Hirsch M, Steigbigel R, Staszewski S, Mellors J, Scerpella E, Hirschel B, Lange J, Squires K, Rawlins S, Meibohm A, Leavitt R.
    J Infect Dis; 1999 Sep 12; 180(3):659-65. PubMed ID: 10438352
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Logarithmic relationship of the CD4 count to survival in patients with human immunodeficiency virus infection.
    Nightingale SD, Jockusch JD, Haslund I, Cal SX, Peterson DM, Loss SD.
    Arch Intern Med; 1993 Jun 14; 153(11):1313-8. PubMed ID: 8099477
    [Abstract] [Full Text] [Related]

  • 12. The impact of ethanol and Marinol/marijuana usage on HIV+/AIDS patients undergoing azidothymidine, azidothymidine/dideoxycytidine, or dideoxyinosine therapy.
    Whitfield RM, Bechtel LM, Starich GH.
    Alcohol Clin Exp Res; 1997 Feb 14; 21(1):122-7. PubMed ID: 9046384
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Value of HIV-1 viral load and CD4 lymphocyte count as determinants of progression to AIDS and survival].
    Romeu J, Balagué M, Ruiz L, Marfil S, Puig T, Arnó A, Veny A, Tural C, Sirera G, Clotet B.
    Med Clin (Barc); 1998 Jun 06; 110(20):761-7. PubMed ID: 9666416
    [Abstract] [Full Text] [Related]

  • 15. Improvement of the predictive value of CD4+ lymphocyte count by beta 2-microglobulin, immunoglobulin A and erythrocyte sedimentation rate. The Multicentre Cohort Study Group.
    Schwartländer B, Bek B, Skarabis H, Koch J, Burkowitz J, Koch MA.
    AIDS; 1993 Jun 06; 7(6):813-21. PubMed ID: 8103341
    [Abstract] [Full Text] [Related]

  • 16. Rapid plasma virus and CD4+ T-cell turnover in HIV-1 infection: evidence for an only transient interruption by treatment.
    Stellbrink HJ, Zöller B, Fenner T, Lichtenberg G, van Lunzen J, Albrecht H, Thiele HG, Greten H.
    AIDS; 1996 Jul 06; 10(8):849-57. PubMed ID: 8828742
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Another AIDS drug. Azidothymidine--dideoxycytidine].
    Moosmann EB.
    Fortschr Med; 1992 Jun 30; 110(18):28-30. PubMed ID: 1353746
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.